Compare AstraZeneca plc (AZN) vs Bit Digital Inc (BTBT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Bit Digital Inc — how do they compare? AstraZeneca plc trades at $158.76 (market cap $248.14B), while Bit Digital Inc trades at $1.47 (market cap $471.05M). The key difference: AstraZeneca plc is far larger — about 526.8× Bit Digital Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Bit Digital Inc pays none. Which is the better fit depends on your goals.
| AZN | BTBT | |
|---|---|---|
Market Cap | $248.14B | $471.05M |
Sector | Health | Technology |
52-Week High | $209.48 | $4.22 |
52-Week Low | $147.06 | $1.23 |
Enterprise Value | $275.41B | $760.36M |
Dividend Yield | 2.01% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $158.48, down 2.12% amid bearish technical signals and merger speculation. The stock shows strong fundamentals with revenue growth from $54.1B in 2024 to $58.7B in 2025 and net income reaching $10.2B. Recent earnings beats and a 47.5% analyst buy rating contrast with technical indicators showing oversold conditions near key support at $155.
Investment outlook remains positive based on earnings momentum and valuation metrics (P/E 23.76), though risks include potential merger integration challenges and ongoing legal investigations. The company's robust cash flow generation and dividend payments provide shareholder value support despite near-term volatility.
BTBT trades at $1.46, up 12.31% today, but the technical outlook is bearish with selling pressure outweighing buying signals. Fundamentally, the company reported a net loss of $80.32 million in 2025, with a negative net income margin of -145.45% in 2026, indicating severe profitability challenges despite a gross margin above 55%. Recent earnings have missed expectations in two of the last three quarters.
The outlook remains challenged by persistent losses and negative cash flow from operations. While analyst coverage is limited and currently shows a 100% buy rating from two firms, significant execution risk and reliance on financing activities to offset operational cash burns present substantial headwinds for shareholder value appreciation in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Bit Digital Inc
Bit Digital is a sustainability-focused digital asset production company. It primarily engages in Bitcoin mining and Ethereum staking while also providing high-performance computing (HPC) infrastructure for AI applications.
Read more on BTBT →
